This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-15a-5p | ABCB5 | 0 | 0 | 0 | 0 | MirTarget | -0.85 | 0 | NA | |
2 | hsa-miR-15a-5p | ABHD13 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
3 | hsa-miR-15a-5p | ACOX1 | 0 | 0 | 0 | 0 | miRNATAP | -0.12 | 1.0E-5 | NA | |
4 | hsa-miR-15a-5p | ACSL4 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.35 | 0 | NA | |
5 | hsa-miR-15a-5p | ACSS2 | 0 | 0 | 0 | 0 | MirTarget | -0.11 | 0.0013 | NA | |
6 | hsa-miR-15a-5p | ACVR2A | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.37 | 0 | NA | |
7 | hsa-miR-15a-5p | ACVR2B | 0 | 0 | 0 | 0 | miRNATAP | -0.18 | 0 | NA | |
8 | hsa-miR-15a-5p | ADAMTS18 | 0 | 0 | 0 | 0 | miRNATAP | -0.6 | 0 | NA | |
9 | hsa-miR-15a-5p | ADAMTS3 | 0 | 0 | 0 | 0 | miRNATAP | -0.4 | 0 | NA | |
10 | hsa-miR-15a-5p | ADAMTS5 | 0 | 0 | 0 | 0 | miRNATAP | -0.79 | 0 | NA | |
11 | hsa-miR-15a-5p | ADAMTSL3 | 0 | 0 | 0 | 0 | MirTarget | -0.46 | 0 | NA | |
12 | hsa-miR-15a-5p | ADCY1 | 0 | 0 | 0 | 0 | mirMAP | -0.27 | 0.00416 | NA | |
13 | hsa-miR-15a-5p | ADCY5 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.65 | 0 | NA | |
14 | hsa-miR-15a-5p | ADRB2 | 0 | 0 | 0 | 0 | MirTarget | -0.5 | 0 | NA | |
15 | hsa-miR-15a-5p | AEBP2 | 0 | 0 | 0 | 0 | MirTarget | -0.14 | 0 | NA | |
16 | hsa-miR-15a-5p | AFF4 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.32 | 0 | NA | |
17 | hsa-miR-15a-5p | AGPAT4 | 0 | 0 | 0 | 0 | mirMAP | -0.11 | 0.01325 | NA | |
18 | hsa-miR-15a-5p | AHCYL2 | 0 | 0 | 0 | 0 | miRNATAP | -0.19 | 0 | NA | |
19 | hsa-miR-15a-5p | AKAP11 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.26 | 0 | NA | |
20 | hsa-miR-15a-5p | AKT3 | 0 | 0 | 0 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.51 | 0 | NA | |
21 | hsa-miR-15a-5p | ALX4 | 0 | 0 | 0 | 0 | mirMAP | -0.84 | 0 | NA | |
22 | hsa-miR-15a-5p | AMMECR1L | 0 | 0 | 0 | 0 | MirTarget | -0.15 | 0 | NA | |
23 | hsa-miR-15a-5p | AMOTL1 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.53 | 0 | NA | |
24 | hsa-miR-15a-5p | ANK2 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.47 | 0 | NA | |
25 | hsa-miR-15a-5p | ANKIB1 | 0 | 0 | 0 | 0 | miRNATAP | -0.19 | 0 | NA | |
26 | hsa-miR-15a-5p | ANKRD29 | 0 | 0 | 0 | 0 | MirTarget | -0.53 | 0 | NA | |
27 | hsa-miR-15a-5p | ANKRD46 | 0 | 0 | 0 | 0 | MirTarget | -0.13 | 5.0E-5 | NA | |
28 | hsa-miR-15a-5p | ANKS1A | 0 | 0 | 0 | 0 | MirTarget | -0.12 | 0 | NA | |
29 | hsa-miR-15a-5p | ANO3 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.65 | 0 | NA | |
30 | hsa-miR-15a-5p | APLNR | 0 | 0 | 0 | 0 | MirTarget | -0.12 | 0.00686 | NA | |
31 | hsa-miR-15a-5p | APP | 0 | 0 | 0 | 0 | miRNAWalker2 validate; miRNATAP | -0.18 | 0 | NA | |
32 | hsa-miR-15a-5p | AR | 0 | 0 | 0 | 0 | mirMAP; miRNATAP | -0.95 | 0 | NA | |
33 | hsa-miR-15a-5p | ARHGAP12 | 0 | 0 | 0 | 0 | miRNATAP | -0.3 | 0 | NA | |
34 | hsa-miR-15a-5p | ARHGAP19 | 0 | 0 | 0 | 0 | MirTarget; mirMAP | -0.22 | 0 | NA | |
35 | hsa-miR-15a-5p | ARHGAP20 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.87 | 0 | NA | |
36 | hsa-miR-15a-5p | ARHGAP32 | 0 | 0 | 0 | 0 | MirTarget | -0.29 | 0 | NA | |
37 | hsa-miR-15a-5p | ARHGAP5 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.38 | 0 | NA | |
38 | hsa-miR-15a-5p | ARHGEF12 | 0 | 0 | 0 | 0 | MirTarget | -0.38 | 0 | NA | |
39 | hsa-miR-15a-5p | ARIH1 | 0 | 0 | 0 | 0 | MirTarget | -0.23 | 0 | NA | |
40 | hsa-miR-15a-5p | ARMC8 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.1 | 0 | NA | |
41 | hsa-miR-15a-5p | ASB1 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.1 | 5.0E-5 | NA | |
42 | hsa-miR-15a-5p | ASH1L | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
43 | hsa-miR-15a-5p | ASNSD1 | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.11 | 0 | NA | |
44 | hsa-miR-15a-5p | ASPH | 0 | 0 | 0 | 0 | miRNATAP | -0.29 | 0 | NA | |
45 | hsa-miR-15a-5p | ASTN1 | 0 | 0 | 0 | 0 | MirTarget | -0.73 | 0 | NA | |
46 | hsa-miR-15a-5p | ASXL2 | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.58 | 0 | NA | |
47 | hsa-miR-15a-5p | ATF2 | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.36 | 0 | NA | |
48 | hsa-miR-15a-5p | ATF6 | 0 | 0 | 0 | 0 | MirTarget | -0.16 | 0 | NA | |
49 | hsa-miR-15a-5p | ATP13A3 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
50 | hsa-miR-15a-5p | ATP7A | 0 | 0 | 0 | 0 | MirTarget | -0.39 | 0 | NA | |
51 | hsa-miR-15a-5p | ATP8A1 | 0 | 0 | 0 | 0 | MirTarget | -0.26 | 0 | NA | |
52 | hsa-miR-15a-5p | ATXN1L | 0 | 0 | 0 | 0 | miRNATAP | -0.34 | 0 | NA | |
53 | hsa-miR-15a-5p | ATXN7L1 | 0 | 0 | 0 | 0 | miRNATAP | -0.14 | 0 | NA | |
54 | hsa-miR-15a-5p | ATXN7L3B | 0 | 0 | 0 | 0 | MirTarget | -0.2 | 0 | NA | |
55 | hsa-miR-15a-5p | AVL9 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.27 | 0 | NA | |
56 | hsa-miR-15a-5p | AXIN2 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.31 | 0 | 26252081 | The combination of miR-15a and AXIN2 significantly improved the diagnostic accuracy |
57 | hsa-miR-15a-5p | BACE1 | 0 | 0 | 0 | 0 | miRNAWalker2 validate; miRNATAP | -0.27 | 0 | NA | |
58 | hsa-miR-15a-5p | BACH2 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.57 | 0 | NA | |
59 | hsa-miR-15a-5p | BAG4 | 0 | 0 | 0 | 0 | MirTarget | -0.3 | 0 | NA | |
60 | hsa-miR-15a-5p | BAG5 | 0 | 0 | 0 | 0 | miRNATAP | -0.16 | 0 | NA | |
61 | hsa-miR-15a-5p | BAZ2A | 0 | 0 | 0 | 0 | miRNATAP | -0.14 | 0 | NA | |
62 | hsa-miR-15a-5p | BCL2 | 0 | 0 | 0 | 0 | miRNAWalker2 validate; miRTarBase | -0.39 | 0 | 25594541; 22335947; 26915294; 18931683; 25623762 | MicroRNAs miRNAs encoded by the miR-15 cluster are known to induce G1 arrest and apoptosis by targeting G1 checkpoints and the anti-apoptotic B cell lymphoma 2 BCL-2 gene;The expression of MiR-15a was significantly inhibited by Bcl-2 P < 0.05;As a result transcript levels of the tumor-suppressive miR-15 and let-7 families increased which targeted and decreased the expression of the crucial prosurvival genes BCL-2 and BCL-XL respectively;MicroRNAs miRNAs are noncoding small RNAs that repress protein translation by targeting specific messenger RNAs miR-15a and miR-16-1 act as putative tumor suppressors by targeting the oncogene BCL2;miR 15a and miR 16 modulate drug resistance by targeting bcl 2 in human colon cancer cells; To investigate the reversal effect of targeted modulation of bcl-2 expression by miR-15a and miR-16 on drug resistance of human colon cancer cells |
63 | hsa-miR-15a-5p | BCL2L13 | 0 | 0 | 0 | 0 | MirTarget | -0.1 | 0 | NA | |
64 | hsa-miR-15a-5p | BCL2L2 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.12 | 0 | 25874488 | MicroRNA 15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non small cell lung cancer; Furthermore we identified that BCL2L2 was a target of miR-15a and negatively regulated by miR-15a at the translational level; miR-15a acts as a tumor suppressor in NSCLC by directly targeting BCL2L2 and may serve as a potential diagnostic biomarker and therapeutic target for NSCLC |
65 | hsa-miR-15a-5p | BDNF | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.27 | 0.0009 | 26581909 | MicroRNA 15a 5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF; BDNF was then overexpressed in HepG2 and SNU-182 cells to evaluate its selective effect on miR-15a-5p in HCC modulation; MiR-15a-5p selectively and negatively regulated BDNF at both gene and protein levels in HCC cells; Forced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-15a-5p on HCC proliferation and cell division in vitro; Our study demonstrated that miR-15a-5p is a tumor suppressor in HCC and its regulation is through BDNF in HCC |
66 | hsa-miR-15a-5p | BHLHE41 | 0 | 0 | 0 | 0 | miRNATAP | -0.5 | 0 | NA | |
67 | hsa-miR-15a-5p | BMI1 | 0 | 0 | 0 | 0 | miRNAWalker2 validate; miRTarBase | -0.11 | 0.00226 | 27596816 | Our results suggest that overexpression of miR-15a and miR-16 mediates down-regulation of BMI1 and leads to mitochondrial mediated apoptosis |
68 | hsa-miR-15a-5p | BMX | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.66 | 0 | NA | |
69 | hsa-miR-15a-5p | BPTF | 0 | 0 | 0 | 0 | miRNATAP | -0.3 | 0 | NA | |
70 | hsa-miR-15a-5p | BRPF3 | 0 | 0 | 0 | 0 | miRNATAP | -0.17 | 0 | NA | |
71 | hsa-miR-15a-5p | BRWD1 | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.18 | 0 | NA | |
72 | hsa-miR-15a-5p | BRWD3 | 0 | 0 | 0 | 0 | MirTarget | -0.32 | 0 | NA | |
73 | hsa-miR-15a-5p | BTAF1 | 0 | 0 | 0 | 0 | MirTarget | -0.33 | 0 | NA | |
74 | hsa-miR-15a-5p | BTBD19 | 0 | 0 | 0 | 0 | mirMAP | -0.28 | 0 | NA | |
75 | hsa-miR-15a-5p | BTG2 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.18 | 0.00165 | NA | |
76 | hsa-miR-15a-5p | BTRC | 0 | 0 | 0 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.19 | 0 | NA | |
77 | hsa-miR-15a-5p | BVES | 0 | 0 | 0 | 0 | MirTarget | -0.42 | 0 | NA | |
78 | hsa-miR-15a-5p | C16orf52 | 0 | 0 | 0 | 0 | miRNATAP | -0.15 | 0 | NA | |
79 | hsa-miR-15a-5p | C1QL3 | 0 | 0 | 0 | 0 | miRNATAP | -0.36 | 1.0E-5 | NA | |
80 | hsa-miR-15a-5p | C1orf21 | 0 | 0 | 0 | 0 | mirMAP; miRNATAP | -0.2 | 0.00024 | NA | |
81 | hsa-miR-15a-5p | C2orf72 | 0 | 0 | 0 | 0 | miRNATAP | -0.52 | 0 | NA | |
82 | hsa-miR-15a-5p | C3orf58 | 0 | 0 | 0 | 0 | miRNATAP | -0.19 | 2.0E-5 | NA | |
83 | hsa-miR-15a-5p | CAB39 | 0 | 0 | 0 | 0 | miRNATAP | -0.15 | 0 | NA | |
84 | hsa-miR-15a-5p | CACNB4 | 0 | 0 | 0 | 0 | miRNATAP | -0.52 | 0 | NA | |
85 | hsa-miR-15a-5p | CADM1 | 0 | 0 | 0 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.2 | 4.0E-5 | NA | |
86 | hsa-miR-15a-5p | CALD1 | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.39 | 0 | NA | |
87 | hsa-miR-15a-5p | CALN1 | 0 | 0 | 0 | 0 | mirMAP | -0.67 | 0 | NA | |
88 | hsa-miR-15a-5p | CAMSAP1 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
89 | hsa-miR-15a-5p | CAPN6 | 0 | 0 | 0 | 0 | miRNATAP | -0.43 | 0.0014 | NA | |
90 | hsa-miR-15a-5p | CAPRIN1 | 0 | 0 | 0 | 0 | MirTarget | -0.11 | 1.0E-5 | NA | |
91 | hsa-miR-15a-5p | CAPZA2 | 0 | 0 | 0 | 0 | MirTarget | -0.11 | 0 | NA | |
92 | hsa-miR-15a-5p | CASK | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.14 | 1.0E-5 | NA | |
93 | hsa-miR-15a-5p | CASZ1 | 0 | 0 | 0 | 0 | MirTarget | -0.11 | 0.00585 | NA | |
94 | hsa-miR-15a-5p | CBX5 | 0 | 0 | 0 | 0 | miRNATAP | -0.15 | 0 | NA | |
95 | hsa-miR-15a-5p | CCDC144A | 0 | 0 | 0 | 0 | mirMAP | -0.57 | 0 | NA | |
96 | hsa-miR-15a-5p | CCDC6 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.18 | 0 | NA | |
97 | hsa-miR-15a-5p | CCND2 | 0 | 0 | 0 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.38 | 0 | NA | |
98 | hsa-miR-15a-5p | CCNJ | 0 | 0 | 0 | 0 | miRNATAP | -0.14 | 1.0E-5 | NA | |
99 | hsa-miR-15a-5p | CCNJL | 0 | 0 | 0 | 0 | miRNATAP | -0.26 | 2.0E-5 | NA | |
100 | hsa-miR-15a-5p | CCNT1 | 0 | 0 | 0 | 0 | miRNATAP | -0.76 | 0 | NA | |
101 | hsa-miR-15a-5p | CCNT2 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.22 | 0 | NA | |
102 | hsa-miR-15a-5p | CCNYL1 | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.13 | 2.0E-5 | NA | |
103 | hsa-miR-15a-5p | CCT6B | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.15 | 0.00017 | NA | |
104 | hsa-miR-15a-5p | CD164 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.11 | 0.00014 | NA | |
105 | hsa-miR-15a-5p | CD274 | 0 | 0 | 0 | 0 | MirTarget | -0.29 | 0 | NA | |
106 | hsa-miR-15a-5p | CD2AP | 0 | 0 | 0 | 0 | miRNATAP | -0.12 | 4.0E-5 | NA | |
107 | hsa-miR-15a-5p | CD47 | 0 | 0 | 0 | 0 | MirTarget | -0.16 | 0 | NA | |
108 | hsa-miR-15a-5p | CDC14B | 0 | 0 | 0 | 0 | miRNAWalker2 validate; MirTarget | -0.48 | 0 | NA | |
109 | hsa-miR-15a-5p | CDC27 | 0 | 0 | 0 | 0 | miRNATAP | -0.13 | 0 | NA | |
110 | hsa-miR-15a-5p | CDC42SE2 | 0 | 0 | 0 | 0 | MirTarget | -0.15 | 0 | NA | |
111 | hsa-miR-15a-5p | CDK17 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.24 | 0 | NA | |
112 | hsa-miR-15a-5p | CDK6 | 0 | 0 | 0 | 0 | miRNATAP | -0.31 | 0 | NA | |
113 | hsa-miR-15a-5p | CDS2 | 0 | 0 | 0 | 0 | mirMAP; miRNATAP | -0.11 | 0 | NA | |
114 | hsa-miR-15a-5p | CEP350 | 0 | 0 | 0 | 0 | miRNATAP | -0.18 | 0 | NA | |
115 | hsa-miR-15a-5p | CHD2 | 0 | 0 | 0 | 0 | MirTarget | -0.17 | 0 | NA | |
116 | hsa-miR-15a-5p | CHD9 | 0 | 0 | 0 | 0 | miRNATAP | -0.44 | 0 | NA | |
117 | hsa-miR-15a-5p | CHPT1 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.18 | 8.0E-5 | NA | |
118 | hsa-miR-10a-5p | CHRNA5 | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.35 | 0 | NA | |
119 | hsa-miR-15a-5p | CHUK | 0 | 0 | 0 | 0 | miRNAWalker2 validate; miRTarBase; MirTarget | -0.14 | 0 | NA | |
120 | hsa-miR-15a-5p | CLCN3 | 0 | 0 | 0 | 0 | miRTarBase | -0.4 | 0 | NA | |
121 | hsa-miR-15a-5p | CLDN12 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
122 | hsa-miR-15a-5p | CLOCK | 0 | 0 | 0 | 0 | MirTarget | -0.45 | 0 | NA | |
123 | hsa-miR-15a-5p | CNKSR2 | 0 | 0 | 0 | 0 | miRNATAP | -0.71 | 0 | NA | |
124 | hsa-miR-15a-5p | CNN1 | 0 | 0 | 0 | 0 | miRNATAP | -0.66 | 0 | NA | |
125 | hsa-miR-15a-5p | CNN3 | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.24 | 0 | NA | |
126 | hsa-miR-15a-5p | COBLL1 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.4 | 0 | NA | |
127 | hsa-miR-15a-5p | COL12A1 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.32 | 0 | NA | |
128 | hsa-miR-15a-5p | COL4A3BP | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.3 | 0 | NA | |
129 | hsa-miR-15a-5p | COPS2 | 0 | 0 | 0 | 0 | MirTarget | -0.15 | 0 | NA | |
130 | hsa-miR-15a-5p | CPD | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.32 | 0 | NA | |
131 | hsa-miR-15a-5p | CPEB2 | 0 | 0 | 0 | 0 | miRNATAP | -0.29 | 0 | NA | |
132 | hsa-miR-15a-5p | CPEB3 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.3 | 0 | NA | |
133 | hsa-miR-15a-5p | CREB5 | 0 | 0 | 0 | 0 | miRNATAP | -0.46 | 0 | NA | |
134 | hsa-miR-15a-5p | CREBL2 | 0 | 0 | 0 | 0 | miRNAWalker2 validate | -0.23 | 0 | NA | |
135 | hsa-miR-15a-5p | CRIM1 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.55 | 0 | NA | |
136 | hsa-miR-15a-5p | CRTC3 | 0 | 0 | 0 | 0 | miRNATAP | -0.15 | 0 | NA | |
137 | hsa-miR-15a-5p | CSDE1 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
138 | hsa-miR-15a-5p | CSF1 | 0 | 0 | 0 | 0 | miRNATAP | -0.1 | 0.02245 | NA | |
139 | hsa-miR-15a-5p | CSRNP1 | 0 | 0 | 0 | 0 | MirTarget | -0.25 | 0 | NA | |
140 | hsa-miR-15a-5p | CTDSPL | 0 | 0 | 0 | 0 | miRNATAP | -0.16 | 0 | NA | |
141 | hsa-miR-15a-5p | CX3CL1 | 0 | 0 | 0 | 0 | miRNATAP | -0.32 | 1.0E-5 | NA | |
142 | hsa-miR-15a-5p | CYP26B1 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.24 | 0.00048 | NA | |
143 | hsa-miR-15a-5p | CYS1 | 0 | 0 | 0 | 0 | mirMAP | -0.43 | 0 | NA | |
144 | hsa-miR-15a-5p | DCAF5 | 0 | 0 | 0 | 0 | MirTarget; miRNATAP | -0.1 | 0 | NA | |
145 | hsa-miR-15a-5p | DCLK1 | 0 | 0 | 0 | 0 | miRNATAP | -0.25 | 0.00208 | NA | |
146 | hsa-miR-15a-5p | DCP1A | 0 | 0 | 0 | 0 | MirTarget | -0.22 | 0 | NA | |
147 | hsa-miR-15a-5p | DCUN1D1 | 0 | 0 | 0 | 0 | MirTarget | -0.2 | 0 | NA | |
148 | hsa-miR-15a-5p | DCX | 0 | 0 | 0 | 0 | mirMAP | -0.42 | 0.00244 | NA | |
149 | hsa-miR-15a-5p | DDX3X | 0 | 0 | 0 | 0 | miRNATAP | -0.24 | 0 | NA | |
150 | hsa-miR-15a-5p | DENND1B | 0 | 0 | 0 | 0 | miRNATAP | -0.28 | 2.0E-5 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PROTEIN PHOSPHORYLATION | 80 | 944 | 1.21e-14 | 5.632e-11 |
2 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 67 | 788 | 1.804e-12 | 2.798e-09 |
3 | CIRCULATORY SYSTEM DEVELOPMENT | 67 | 788 | 1.804e-12 | 2.798e-09 |
4 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 121 | 1977 | 2.197e-11 | 2.555e-08 |
5 | PHOSPHORYLATION | 85 | 1228 | 9.683e-11 | 9.011e-08 |
6 | NEUROGENESIS | 90 | 1402 | 1.228e-09 | 8.434e-07 |
7 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 107 | 1784 | 1.269e-09 | 8.434e-07 |
8 | HEART DEVELOPMENT | 42 | 466 | 5.5e-09 | 3.199e-06 |
9 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 53 | 689 | 1.393e-08 | 6.481e-06 |
10 | CELL DEVELOPMENT | 88 | 1426 | 1.264e-08 | 6.481e-06 |
11 | ORGAN MORPHOGENESIS | 60 | 841 | 2.375e-08 | 8.845e-06 |
12 | REGULATION OF CELL DIFFERENTIATION | 90 | 1492 | 2.475e-08 | 8.845e-06 |
13 | RESPONSE TO GROWTH FACTOR | 41 | 475 | 2.851e-08 | 8.845e-06 |
14 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 13 | 56 | 2.786e-08 | 8.845e-06 |
15 | TISSUE DEVELOPMENT | 91 | 1518 | 2.742e-08 | 8.845e-06 |
16 | INTRACELLULAR SIGNAL TRANSDUCTION | 93 | 1572 | 3.537e-08 | 1.028e-05 |
17 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 67 | 1008 | 5.408e-08 | 1.48e-05 |
18 | VASCULATURE DEVELOPMENT | 40 | 469 | 5.843e-08 | 1.51e-05 |
19 | CELLULAR COMPONENT MORPHOGENESIS | 60 | 900 | 2.539e-07 | 6.217e-05 |
20 | POSITIVE REGULATION OF GENE EXPRESSION | 96 | 1733 | 4.521e-07 | 0.0001047 |
21 | NEURON DIFFERENTIATION | 58 | 874 | 4.724e-07 | 0.0001047 |
22 | HEAD DEVELOPMENT | 50 | 709 | 5.204e-07 | 0.0001101 |
23 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 57 | 872 | 9.638e-07 | 0.000195 |
24 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 92 | 1672 | 1.087e-06 | 0.0002107 |
25 | REGULATION OF DEVELOPMENTAL GROWTH | 27 | 289 | 1.513e-06 | 0.0002593 |
26 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 97 | 1805 | 1.512e-06 | 0.0002593 |
27 | PROTEIN DEPHOSPHORYLATION | 21 | 190 | 1.56e-06 | 0.0002593 |
28 | CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 16 | 116 | 1.506e-06 | 0.0002593 |
29 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 60 | 957 | 1.92e-06 | 0.0003081 |
30 | PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 56 | 873 | 2.152e-06 | 0.0003338 |
31 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 90 | 1656 | 2.413e-06 | 0.0003622 |
32 | RESPONSE TO ENDOGENOUS STIMULUS | 81 | 1450 | 2.92e-06 | 0.0004246 |
33 | FOREBRAIN DEVELOPMENT | 30 | 357 | 3.603e-06 | 0.0004831 |
34 | MUSCLE STRUCTURE DEVELOPMENT | 34 | 432 | 3.516e-06 | 0.0004831 |
35 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 53 | 823 | 3.634e-06 | 0.0004831 |
36 | DEPHOSPHORYLATION | 26 | 286 | 3.899e-06 | 0.000504 |
37 | SKELETAL SYSTEM DEVELOPMENT | 35 | 455 | 4.214e-06 | 0.0005299 |
38 | EMBRYO DEVELOPMENT | 56 | 894 | 4.405e-06 | 0.0005393 |
39 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 67 | 1142 | 4.613e-06 | 0.0005504 |
40 | POSITIVE REGULATION OF LOCOMOTION | 33 | 420 | 5.064e-06 | 0.000589 |
41 | NEURON PROJECTION DEVELOPMENT | 39 | 545 | 6.763e-06 | 0.0007675 |
42 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 14 | 103 | 8.032e-06 | 0.0008691 |
43 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 14 | 103 | 8.032e-06 | 0.0008691 |
44 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 22 | 229 | 8.945e-06 | 0.0009003 |
45 | HEART MORPHOGENESIS | 21 | 212 | 8.891e-06 | 0.0009003 |
46 | REGULATION OF PROTEIN MODIFICATION PROCESS | 90 | 1710 | 8.741e-06 | 0.0009003 |
47 | REGULATION OF CELL MORPHOGENESIS | 39 | 552 | 9.094e-06 | 0.0009003 |
48 | PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 16 | 134 | 1.012e-05 | 0.0009233 |
49 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 37 | 513 | 9.765e-06 | 0.0009233 |
50 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 86 | 1618 | 9.799e-06 | 0.0009233 |
51 | BIOLOGICAL ADHESION | 61 | 1032 | 1.005e-05 | 0.0009233 |
52 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 36 | 498 | 1.224e-05 | 0.001096 |
53 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 71 | 1275 | 1.401e-05 | 0.00123 |
54 | POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 7 | 26 | 1.665e-05 | 0.001394 |
55 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 59 | 1004 | 1.678e-05 | 0.001394 |
56 | INOSITOL LIPID MEDIATED SIGNALING | 15 | 124 | 1.626e-05 | 0.001394 |
57 | MUSCLE ORGAN DEVELOPMENT | 24 | 277 | 2.03e-05 | 0.001657 |
58 | DEVELOPMENTAL GROWTH | 27 | 333 | 2.082e-05 | 0.001671 |
59 | EPITHELIUM DEVELOPMENT | 56 | 945 | 2.191e-05 | 0.001728 |
60 | COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 9 | 48 | 2.5e-05 | 0.001939 |
61 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 59 | 1021 | 2.731e-05 | 0.002083 |
62 | NEURON DEVELOPMENT | 44 | 687 | 2.818e-05 | 0.002115 |
63 | PATTERN SPECIFICATION PROCESS | 31 | 418 | 3.006e-05 | 0.00222 |
64 | PROTEIN UBIQUITINATION | 41 | 629 | 3.553e-05 | 0.002583 |
65 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 46 | 740 | 3.866e-05 | 0.002768 |
66 | REGIONALIZATION | 25 | 311 | 4.806e-05 | 0.003388 |
67 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 37 | 554 | 5.137e-05 | 0.003519 |
68 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 47 | 771 | 5.143e-05 | 0.003519 |
69 | INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 14 | 6.288e-05 | 0.00424 |
70 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 26 | 337 | 6.79e-05 | 0.004476 |
71 | PROTEIN POLYUBIQUITINATION | 21 | 243 | 6.829e-05 | 0.004476 |
72 | NEURON MIGRATION | 13 | 110 | 7.526e-05 | 0.004864 |
73 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 18 | 194 | 9.015e-05 | 0.005692 |
74 | NEGATIVE REGULATION OF OSSIFICATION | 10 | 69 | 9.052e-05 | 0.005692 |
75 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 15 | 144 | 9.43e-05 | 0.00585 |
76 | BLOOD VESSEL MORPHOGENESIS | 27 | 364 | 9.624e-05 | 0.005892 |
77 | REGULATION OF OSSIFICATION | 17 | 178 | 9.834e-05 | 0.005943 |
78 | EMBRYONIC PATTERN SPECIFICATION | 9 | 58 | 0.000118 | 0.007042 |
79 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 57 | 1036 | 0.0001405 | 0.008071 |
80 | REGULATION OF EPITHELIAL CELL MIGRATION | 16 | 166 | 0.0001403 | 0.008071 |
81 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 57 | 1036 | 0.0001405 | 0.008071 |
82 | TISSUE REMODELING | 11 | 87 | 0.0001446 | 0.008205 |
83 | POSITIVE REGULATION OF GROWTH | 20 | 238 | 0.0001478 | 0.008284 |
84 | GLAND DEVELOPMENT | 28 | 395 | 0.0001553 | 0.008603 |
85 | REGULATION OF DENDRITE MORPHOGENESIS | 10 | 74 | 0.0001648 | 0.008793 |
86 | PEPTIDYL TYROSINE MODIFICATION | 17 | 186 | 0.0001682 | 0.008793 |
87 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 12 | 103 | 0.0001618 | 0.008793 |
88 | CELL PROJECTION ORGANIZATION | 51 | 902 | 0.0001649 | 0.008793 |
89 | CELL GROWTH | 14 | 135 | 0.0001676 | 0.008793 |
90 | CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 18 | 204 | 0.0001706 | 0.00882 |
91 | MEMBRANE DEPOLARIZATION | 9 | 61 | 0.0001759 | 0.008975 |
92 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 12 | 104 | 0.0001775 | 0.008975 |
93 | REGULATION OF CELL DEVELOPMENT | 48 | 836 | 0.0001799 | 0.009002 |
94 | POSITIVE REGULATION OF CELL COMMUNICATION | 77 | 1532 | 0.0001832 | 0.00907 |
95 | PALLIUM DEVELOPMENT | 15 | 153 | 0.0001862 | 0.00912 |
96 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 8 | 49 | 0.0001955 | 0.009475 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PROTEIN KINASE ACTIVITY | 63 | 640 | 1.255e-14 | 1.166e-11 |
2 | KINASE ACTIVITY | 69 | 842 | 4.533e-12 | 2.106e-09 |
3 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 72 | 992 | 3.956e-10 | 1.225e-07 |
4 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 42 | 445 | 1.395e-09 | 3.241e-07 |
5 | ADENYL NUCLEOTIDE BINDING | 89 | 1514 | 9.684e-08 | 1.799e-05 |
6 | ENZYME BINDING | 98 | 1737 | 1.431e-07 | 2.215e-05 |
7 | UBIQUITIN LIKE PROTEIN TRANSFERASE ACTIVITY | 35 | 420 | 6.833e-07 | 9.069e-05 |
8 | RIBONUCLEOTIDE BINDING | 100 | 1860 | 9.928e-07 | 0.0001153 |
9 | UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 21 | 199 | 3.289e-06 | 0.0003395 |
10 | SMAD BINDING | 12 | 72 | 4.154e-06 | 0.000386 |
11 | PHOSPHATASE ACTIVITY | 25 | 275 | 5.961e-06 | 0.0005035 |
12 | PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 11 | 64 | 7.671e-06 | 0.0005789 |
13 | PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 19 | 178 | 8.1e-06 | 0.0005789 |
14 | UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 8 | 34 | 1.222e-05 | 0.0008109 |
15 | MACROMOLECULAR COMPLEX BINDING | 76 | 1399 | 1.619e-05 | 0.001003 |
16 | KINASE BINDING | 40 | 606 | 3.343e-05 | 0.001941 |
17 | PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 7 | 29 | 3.621e-05 | 0.001979 |
18 | ZINC ION BINDING | 64 | 1155 | 4.409e-05 | 0.002275 |
19 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 11 | 81 | 7.496e-05 | 0.003665 |
20 | PROTEIN TYROSINE KINASE ACTIVITY | 17 | 176 | 8.551e-05 | 0.003972 |
21 | LIGASE ACTIVITY | 29 | 406 | 0.0001044 | 0.004621 |
22 | PHOSPHORIC ESTER HYDROLASE ACTIVITY | 27 | 368 | 0.0001154 | 0.004872 |
23 | PDZ DOMAIN BINDING | 11 | 90 | 0.0001963 | 0.00793 |
24 | MICROTUBULE MOTOR ACTIVITY | 10 | 77 | 0.0002301 | 0.008906 |
25 | ATP DEPENDENT MICROTUBULE MOTOR ACTIVITY | 5 | 18 | 0.0002409 | 0.008951 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEURON PART | 80 | 1265 | 2.206e-08 | 1.288e-05 |
2 | NEURON PROJECTION | 64 | 942 | 4.936e-08 | 1.441e-05 |
3 | CELL PROJECTION | 101 | 1786 | 7.945e-08 | 1.547e-05 |
4 | SOMATODENDRITIC COMPARTMENT | 43 | 650 | 1.613e-05 | 0.002354 |
5 | TRANSFERASE COMPLEX | 45 | 703 | 2.317e-05 | 0.002706 |
6 | CELL PROJECTION PART | 55 | 946 | 4.371e-05 | 0.004254 |
7 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 5 | 14 | 6.288e-05 | 0.00459 |
8 | SYNAPSE | 46 | 754 | 6.063e-05 | 0.00459 |
9 | KINESIN COMPLEX | 9 | 55 | 7.703e-05 | 0.004998 |
10 | RECEPTOR COMPLEX | 25 | 327 | 0.0001076 | 0.006283 |
11 | DENDRITE | 31 | 451 | 0.000123 | 0.006532 |
12 | AXON | 29 | 418 | 0.0001723 | 0.007667 |
13 | PROTEIN KINASE COMPLEX | 11 | 90 | 0.0001963 | 0.007667 |
14 | SODIUM CHANNEL COMPLEX | 5 | 17 | 0.0001789 | 0.007667 |
15 | UBIQUITIN LIGASE COMPLEX | 21 | 262 | 0.0001969 | 0.007667 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | PI3K_Akt_signaling_pathway_hsa04151 | 32 | 352 | 3.048e-07 | 1.585e-05 | |
2 | MAPK_signaling_pathway_hsa04010 | 28 | 295 | 7.07e-07 | 1.838e-05 | |
3 | Focal_adhesion_hsa04510 | 19 | 199 | 3.924e-05 | 0.0005881 | |
4 | mTOR_signaling_pathway_hsa04150 | 16 | 151 | 4.524e-05 | 0.0005881 | |
5 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 14 | 139 | 0.0002281 | 0.002208 | |
6 | Oocyte_meiosis_hsa04114 | 13 | 124 | 0.0002547 | 0.002208 | |
7 | Autophagy_animal_hsa04140 | 13 | 128 | 0.0003483 | 0.002587 | |
8 | FoxO_signaling_pathway_hsa04068 | 13 | 132 | 0.0004696 | 0.003052 | |
9 | Rap1_signaling_pathway_hsa04015 | 17 | 206 | 0.0005574 | 0.003221 | |
10 | Ras_signaling_pathway_hsa04014 | 18 | 232 | 0.0008043 | 0.004182 | |
11 | cGMP_PKG_signaling_pathway_hsa04022 | 14 | 163 | 0.001135 | 0.005364 | |
12 | Regulation_of_actin_cytoskeleton_hsa04810 | 16 | 208 | 0.001678 | 0.00727 | |
13 | Apelin_signaling_pathway_hsa04371 | 12 | 137 | 0.002118 | 0.008472 | |
14 | AMPK_signaling_pathway_hsa04152 | 11 | 121 | 0.002388 | 0.008551 | |
15 | Hippo_signaling_pathway_multiple_species_hsa04392 | 5 | 29 | 0.002467 | 0.008551 | |
16 | Cellular_senescence_hsa04218 | 13 | 160 | 0.002749 | 0.008933 | |
17 | TNF_signaling_pathway_hsa04668 | 10 | 108 | 0.003242 | 0.009918 | |
18 | Mitophagy_animal_hsa04137 | 7 | 65 | 0.005749 | 0.01576 | |
19 | Phosphatidylinositol_signaling_system_hsa04070 | 9 | 99 | 0.00576 | 0.01576 | |
20 | cAMP_signaling_pathway_hsa04024 | 13 | 198 | 0.01556 | 0.04045 | |
21 | Endocytosis_hsa04144 | 15 | 244 | 0.01705 | 0.04223 | |
22 | ECM_receptor_interaction_hsa04512 | 7 | 82 | 0.01942 | 0.04418 | |
23 | Hedgehog_signaling_pathway_hsa04340 | 5 | 47 | 0.01954 | 0.04418 | |
24 | Phospholipase_D_signaling_pathway_hsa04072 | 10 | 146 | 0.0244 | 0.05074 | |
25 | Wnt_signaling_pathway_hsa04310 | 10 | 146 | 0.0244 | 0.05074 | |
26 | p53_signaling_pathway_hsa04115 | 6 | 68 | 0.02551 | 0.05103 | |
27 | Gap_junction_hsa04540 | 7 | 88 | 0.02741 | 0.05279 | |
28 | Calcium_signaling_pathway_hsa04020 | 11 | 182 | 0.04159 | 0.07723 | |
29 | Tight_junction_hsa04530 | 10 | 170 | 0.05854 | 0.105 | |
30 | Hippo_signaling_pathway_hsa04390 | 9 | 154 | 0.07259 | 0.1258 | |
31 | Notch_signaling_pathway_hsa04330 | 4 | 48 | 0.07507 | 0.1259 | |
32 | Adherens_junction_hsa04520 | 5 | 72 | 0.09178 | 0.1491 | |
33 | Sphingolipid_signaling_pathway_hsa04071 | 7 | 118 | 0.09929 | 0.1565 | |
34 | HIF_1_signaling_pathway_hsa04066 | 6 | 100 | 0.1168 | 0.1786 | |
35 | VEGF_signaling_pathway_hsa04370 | 4 | 59 | 0.1331 | 0.1978 | |
36 | TGF_beta_signaling_pathway_hsa04350 | 5 | 84 | 0.1483 | 0.2142 | |
37 | Jak_STAT_signaling_pathway_hsa04630 | 8 | 162 | 0.1736 | 0.2429 | |
38 | Apoptosis_hsa04210 | 7 | 138 | 0.1775 | 0.2429 | |
39 | Cell_cycle_hsa04110 | 6 | 124 | 0.2325 | 0.31 | |
40 | Peroxisome_hsa04146 | 4 | 83 | 0.299 | 0.3887 | |
41 | ErbB_signaling_pathway_hsa04012 | 4 | 85 | 0.3141 | 0.3984 | |
42 | Cell_adhesion_molecules_.CAMs._hsa04514 | 6 | 145 | 0.3533 | 0.4374 | |
43 | Ferroptosis_hsa04216 | 2 | 40 | 0.3865 | 0.4609 | |
44 | NF_kappa_B_signaling_pathway_hsa04064 | 4 | 95 | 0.39 | 0.4609 | |
45 | Neuroactive_ligand_receptor_interaction_hsa04080 | 8 | 278 | 0.7113 | 0.8041 | |
46 | Phagosome_hsa04145 | 4 | 152 | 0.7494 | 0.8291 | |
47 | Cytokine_cytokine_receptor_interaction_hsa04060 | 7 | 270 | 0.7989 | 0.8478 | |
48 | Lysosome_hsa04142 | 2 | 123 | 0.9194 | 0.9561 | |
49 | Necroptosis_hsa04217 | 2 | 164 | 0.9747 | 0.9938 |